EXHIBIT 11
DURA PHARMACEUTICALS, INC.
STATEMENTS RE COMPUTATIONS OF NET INCOME PER SHARE
IN THOUSANDS, EXCEPT PER SHARE DATA
THREE MONTHS ENDED SIX MONTHS ENDED
JUNE 30, JUNE 30,
------------------ --------------------
1996 1997 1996 1997
------------------ --------------------
(UNAUDITED) (UNAUDITED)
Net Income ................................... $ 4,609 $ 9,282 $ 8,665 $ 18,069
------- -------- -------- --------
------- -------- -------- --------
Weighted Average Number of Common and Common
Equivalent Shares:
Common stock ............................... 33,819 43,672 32,598 43,511
Stock options .............................. 1,933 1,118 1,955 1,147
Warrants ................................... 2,927 2,537 2,724 2,627
------- -------- -------- --------
Total ..................................... 38,679 47,327 37,277 47,285
------- -------- -------- --------
------- -------- -------- --------
Net Income per Share ......................... $ 0.12 $ 0.20 $ 0.23 $ 0.38
------- -------- -------- --------
------- -------- -------- --------
FULLY DILUTED NET INCOME PER SHARE:
Net Income ................................... $ 4,609 $ 9,282 $ 8,665 $ 18,069
------- -------- -------- --------
------- -------- -------- --------
Weighted Average Number of Common and Common
Equivalent Shares Assuming Issuance of All
Dilutive Contingent Shares:
Common stock ............................... 33,819 43,672 32,598 43,511
Stock options .............................. 1,934 1,174 2,064 1,172
Warrants ................................... 2,928 2,640 3,007 2,683
------- -------- -------- --------
Total ..................................... 38,681 47,486 37,669 47,366
------- -------- -------- --------
------- -------- -------- --------
Net Income per Share ......................... $ 0.12 $ 0.20 $ 0.23 $ 0.38
------- -------- -------- --------
------- -------- -------- --------